Cliff Asness’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$212K Buy
+15,816
New +$236K ﹤0.01% 3880
2025
Q3
– Sell
-25,156
Closed -$100K – 3623
2025
Q2
$100K Buy
+25,156
New +$109K ﹤0.01% 3176

Other funds holding CTNM

Cliff Asness's CTNM Position: Q3 2026 in Review

Cliff Asness opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 15,816 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #3880 among its holdings. This is a return to the name: Cliff Asness previously reported a position in CTNM as recently as Q2 2025.

Cliff Asness first reported a position in CTNM in Q2 2025 and has held it in 2 quarters since. 118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Cliff Asness held 15,816 shares of Contineum Therapeutics worth $212K as of Q3 2026.
  • Contineum Therapeutics was a new Cliff Asness position in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3880 holding.
  • Cliff Asness first reported a position in Contineum Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.